1. Home
  2. Glossary
  3. PARPs

NAD+ glossary · Enzymes & pathways

What are PARPs?

PARPs (poly(ADP-ribose) polymerases) are enzymes that respond when DNA is damaged. They use NAD+ to build chains of ADP-ribose that flag the damage and call in repair proteins.

  • Also calledPoly(ADP-ribose) polymerases
  • CategoryEnzymes & pathways
  • Term15 of 30

Medically reviewed by Vanessa Niles, R.N., M.D., F.A.C.O.G. —

Definition

PARPs, in plain English

PARP1, the best-known member, is described in NIH's gene database as a chromatin-associated enzyme that modifies nuclear proteins. When DNA breaks, PARP1 binds the site and attaches chains of ADP-ribose made from NAD+.

The National Cancer Institute explains it simply: PARP helps repair DNA when it becomes damaged.

Full name
Poly(ADP-ribose) polymerase
Job
DNA damage response
Uses
NAD+ (releases nicotinamide)
DNA strand with a break where a PARP enzyme builds an ADP-ribose chain from NAD+ to call repair proteins
PARP flags broken DNA with chains built from NAD+.

How it connects

Heavy PARP activity can use up NAD+ quickly. Research reviews describe ongoing DNA damage and PARP activity as one of the drains on NAD+ with age.

Browse all 30 NAD+ terms

For your treatment

What PARPs means for NAD+ therapy

PARP inhibitors are cancer drugs that block this repair in some tumor cells. If you're in cancer treatment, NADMedics won't prescribe NAD+ without your oncologist's agreement.

  • Free online consultation with a licensed U.S. provider
  • NAD+ nasal spray or injection, plans from $166 a month if prescribed
  • NAD+ has no FDA-approved use; compounded NAD+ isn’t FDA-approved

Questions

PARPs: common questions

What are PARPs?

PARPs (poly(ADP-ribose) polymerases) are enzymes that respond when DNA is damaged. They use NAD+ to build chains of ADP-ribose that flag the damage and call in repair proteins.

What is a PARP inhibitor?

A cancer medicine that blocks the PARP enzyme so some tumor cells can't repair their DNA, as the National Cancer Institute describes.

Does NAD+ therapy affect PARP?

PARPs use NAD+, but how extra NAD+ affects PARP activity in people hasn't been established.

Does NAD+ therapy change how these enzymes work in people?

That hasn't been shown. Most research on NAD+ enzymes comes from cells and animals.

Are there medicines that target NAD+ enzymes?

Yes, in cancer care: PARP inhibitors treat some cancers, and a CD38 antibody (daratumumab) treats multiple myeloma. They aren't used to raise NAD+.

Why does enzyme research matter for NAD+ therapy?

It explains why NAD+ is worth studying. Plausible biology isn't the same as proof that NAD+ therapy helps people.

Official sources

PARPs: sources and official resources

Official government and research sources behind this page, so you can check the facts yourself.

  1. NIH National Center for Biotechnology InformationPARP1 poly(ADP-ribose) polymerase 1 [human] (NCBI Gene)

    Gene record for PARP1, a chromatin-associated enzyme involved in DNA repair.

  2. National Cancer InstituteNCI Dictionary of Cancer Terms: PARP inhibitor

    PARP helps repair damaged DNA; PARP inhibitors block it in some cancers.

  3. NIH PubMed CentralCovarrubias et al. NAD+ metabolism and its roles in cellular processes during ageing (2021)

    Review of how NAD+ works in cells and how levels change with age.

  4. NIH PubMedNAD+ therapy in age-related degenerative disorders: a benefit/risk analysis (2020)

    Weighs early promise against the lack of long-term human trials.

Medically reviewed by Dr. Vanessa Niles, R.N., M.D., F.A.C.O.G., on October 12, 2026. This glossary is general education, not medical advice. NAD+ has no FDA-approved use, and compounded NAD+ is not FDA-approved or evaluated by the FDA for safety or effectiveness. Talk with a licensed provider before starting any supplement or treatment.

Questions about NAD+? Ask a provider

Book a free online consultation. A licensed U.S. provider reviews your health and, if NAD+ fits, prescribes the nasal spray or injection, with plans from $166 a month.

Book a free consultation